"Lilly's Mounjaro: Britain's New Weight-Loss Drug Launch"

Eli Lilly's weight-loss drug Mounjaro is being launched in the UK, making it the fourth European country to introduce the highly-anticipated obesity drug. The drug, also approved for diabetes, will be available for both private and NHS patients. With a high demand indicated by the popularity of rival weight-loss drug Wegovy, pharmacies are preparing for strong interest. The UK will be the first major market to receive Mounjaro in a more convenient pre-filled injection pen, with a 4-week course priced at around £215 for private patients. The concentration of the active ingredient in the shots needs to build up over months to reach a maintenance level to slowly accustom the body to the appetite-suppressing peptides.